These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 2590312

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Assessment of individual CYP2D6 activity in extensive metabolizers with renal failure: comparison of sparteine and dextromethorphan.
    Kévorkian JP, Michel C, Hofmann U, Jacqz-Aigrain E, Kroemer HK, Peraldi MN, Eichelbaum M, Jaillon P, Funck-Brentano C.
    Clin Pharmacol Ther; 1996 May; 59(5):583-92. PubMed ID: 8646830
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lack of relationship between quinidine pharmacokinetics and the sparteine oxidation polymorphism.
    Nielsen F, Rosholm JU, Brøsen K.
    Eur J Clin Pharmacol; 1995 May; 48(6):501-4. PubMed ID: 8582470
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population.
    Griese EU, Asante-Poku S, Ofori-Adjei D, Mikus G, Eichelbaum M.
    Pharmacogenetics; 1999 Dec; 9(6):715-23. PubMed ID: 10634134
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Moclobemide treatment causes a substantial rise in the sparteine metabolic ratio. Danish University Antidepressant Group.
    Gram LF, Brøsen K.
    Br J Clin Pharmacol; 1993 Jun; 35(6):649-52. PubMed ID: 8329293
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of N-propylajmaline in relation to polymorphic sparteine oxidation.
    Zekorn C, Achtert G, Hausleiter HJ, Moon CH, Eichelbaum M.
    Klin Wochenschr; 1985 Nov 15; 63(22):1180-6. PubMed ID: 4079282
    [Abstract] [Full Text] [Related]

  • 18. Identification of a novel CYP2D6 allele associated with poor metabolism of sparteine in a Japanese population.
    Kondo I, Yonaha M, Okano K, Gonzalez FJ, Kanazawa I.
    Pharmacogenetics; 1991 Dec 15; 1(3):161-4. PubMed ID: 1688247
    [Abstract] [Full Text] [Related]

  • 19. Sparteine oxidation polymorphism: a family study.
    Brøsen K, Otton SV, Gram LF.
    Br J Clin Pharmacol; 1986 Jun 15; 21(6):661-7. PubMed ID: 3741716
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.